Approaches to lipid metabolism gene identification and characterization in the postgenomic era

Journal of Lipid Research

Volumn 47, Issue 9, 2006, Pages 1891-1907

  Reue, Karen ^a   Vergnes, Laurent ^a  

^a NONE

Author keywords

Comparative genomics; Ethylnitrosourea mutagenesis; Functional genomics; Gene trap mutagenesis; Positional cloning

Indexed keywords

FUNCTIONAL GENOMICS; GENE FUNCTION; GENE IDENTIFICATION; GENE SEQUENCE; GENOME ANALYSIS; HUMAN; LIPID METABOLISM; MOLECULAR CLONING; MUTAGENESIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SEQUENCE ANALYSIS;

ANIMALS; COMPUTATIONAL BIOLOGY; DATABASES, GENETIC; GENOME, HUMAN; GENOMICS; HUMANS; LIPID METABOLISM; SEQUENCE ANALYSIS, DNA;

EID: 33748752880     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.R600020-JLR200     Document Type: Review

References (138)

1. International Human Genome Sequencing Consortium. 2001. Initial sequencing and analysis of the human genome. Nature. 409: 860-921.
2. International Human Genome Sequencing Consortium. 2004. Finishing the euchromatic sequence of the human genome. Nature. 431: 931-945.
3. International Mouse Genome Sequencing Consortium. 2002. Initial sequencing and comparative analysis of the mouse genome. Nature. 420: 520-562.
4. Hardison, R. C. 2003. Comparative genomics. PLoS Biol. 1: 156-160.
5. Nobrega, M. A., and L. A. Pennacchio. 2004. Comparative genomic analysis as a tool for biological discovery. J. Physiol. 554: 31-39.
6. Pennacchio, L. A., and E. M. Rubin. 2003. Comparative genomic tools and databases: providing insights into the human genome. J. Clin. Invest. 111: 1099-1106.
7. Tautz, D. 2000. Evolution of transcriptional regulation. Curr. Opin. Genet. Dev. 10: 575-579.
8. Pennacchio, L. A., M. Olivier, J. A. Hubacek, J. C. Cohen, D. R. Cox, J. C. Fruchart, R. M. Krauss, and E. M. Rubin. 2001. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science. 294: 169-173.
9. Talmud, P. J., E. Hawe, S. Martin, M. Olivier, G. J. Miller, E. M. Rubin, L. A. Pennacchio, and S. E. Humphries. 2002. Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. Hum. Mol. Genet. 11: 3039-3046.
10. Vergnes, L., J. Phan, A. Stolz, and K. Reue. 2003. A cluster of eight hydroxysteroid dehydrogenase genes belonging to the aldo-keto reductase supergene family on mouse chromosome 13. J. Lipid Res. 44: 503-511.
11. Bauman, D. R., S. Steckelbroeck, and T. M. Penning. 2004. The roles of aldo-keto reductases in steroid hormone action. Drug News Perspect. 17: 563-578.
12. Zheng, P., L. A. Pennacchio, W. Le Goff, E. M. Rubin, and J. D. Smith. 2004. Identification of a novel enhancer of brain expression near the apoE gene cluster by comparative genomics. Biochim. Biophys. Acta. 1676: 41-50.
13. Lawn, R. M., K. Schwartz, and L. Patthy. 1997. Convergent evolution of apolipoprotein(a) in primates and hedgehog. Proc. Natl. Acad. Sci. USA. 94: 11992-11997.
14. Boffelli, D., J. McAuliffe, D. Ovcharenko, K. D. Lewis, I. Ovcharenko, L. Pachter, and E. M. Rubin. 2003. Phylogenetic shadowing of primate sequences to find functional regions of the human genome. Science. 299: 1391-1394.
15. Ovcharenko, I., D. Boffelli, and G. G. Loots. 2004. eShadow: a tool for comparing closely related sequences. Genome Res. 14: 1191-1198.
16. Loots, G. G., and I. Ovcharenko. 2005. Dcode.org anthology of comparative genomic tools. Nucleic Acids Res. 33: W56-W64.
17. ENCODE Project Consortium. 2004. The ENCODE (ENCyclopedia Of DNA Elements) project. Science. 306: 636-640.
18. The Huntington's Disease Collaborative Research Group. 1993. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell. 72: 971-983.
19. Crawford, D. C., and D. A. Nickerson. 2005. Definition and clinical importance of haplotypes. Annu. Rev. Med. 56: 303-320.
20. DiPetrillo, K., X. Wang, I. M. Stylianou, and B. Paigen. 2005. Bioinformatics toolbox for narrowing rodent quantitative trait loci. Trends Genet. 21: 683-692.
21. Cuppen, E. 2005. Haplotype-based genetics in mice and rats. Trends Genet. 21: 318-322.
22. International HapMap Consortium. 2005. A haplotype map of the human genome. Nature. 437: 1299-1320.
23. Thorisson, G. A., A. V. Smith, L. Krishnan, and L. D. Stein. 2005. The International HapMap Project Web site. Genome Res. 15: 1592-1593.
24. Wade, C. M., E. J. Kulbokas, 3rd, A. W. Kirby, M. C. Zody, J. C. Mullikin, E. S. Lander, K. Lindblad-Toh, and M. J. Daly. 2002. The mosaic structure of variation in the laboratory mouse genome. Nature. 420: 574-578.
25. Herman, G. E. 1998. Physical mapping of the mouse genome. Methods. 14: 135-151.
26. Boehm, T. 1998. Positional cloning and gene identification. Methods. 14: 152-158.
27. The Gene Ontology Consortium. 2000. Gene ontology: tool for the unification of biology. Nat. Genet. 25: 25-29.
28. Su, A. I., T. Wiltshire, S. Batalov, H. Lapp, K. A. Ching, D. Block, J. Zhang, R. Soden, M. Hayakawa, G. Kreiman, et al. 2004. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc. Natl. Acad. Sci. USA. 101: 6062-6067.
29. Behm-Ansmant, I., and E. Izaurralde. 2006. Quality control of gene expression: a stepwise assembly pathway for the surveillance complex that triggers nonsense-mediated mRNA decay. Genes Dev. 20: 391-398.
30. Aitman, T. J., T. Gotoda, A. L. Evans, H. Imrie, K. E. Heath, P. M. Trembling, H. Truman, C. A. Wallace, A. Rahman, C. Dore, et al. 1997. Quantitative trait loci for cellular defects in glucose and fatty acid metabolism in hypertensive rats. Nat. Genet. 16: 197-201.
31. Berge, K. E., H. Tian, G. A. Graf, L. Yu, N. V. Grishin, J. Schultz, P. Kwiterovich, B. Shan, R. Barnes, and H. H. Hobbs. 2000. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science. 290: 1771-1775.
32. Reue, K., and M. H. Doolittle. 1996. Naturally occurring mutations in mice affecting lipid transport and metabolism. J. Lipid Res. 37: 1387-1405.
33. Ho, S. Y., K. Lorent, M. Pack, and S. A. Farber. 2006. Zebrafish fatfree is required for intestinal lipid absorption and Golgi apparatus structure. Cell Metab. 3: 289-300.
34. Mori, M., G. Li, I. Abe, J. Nakayama, Z. Guo, J. Sawashita, T. Ugawa, S. Nishizono, T. Serikawa, K. Higuchi, et al. 2006. Lanosterol synthase mutations cause cholesterol deficiency-associated cataracts in the Shumiya cataract rat. J. Clin. Invest. 116: 395-404.
35. Brooks-Wilson, A., M. Marcil, S. M. Clee, L. H. Zhang, K. Roomp, M. van Dam, L. Yu, C. Brewer, J. A. Collins, H. O. Molhuizen, et al. 1999. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat. Genet. 22: 336-345.
36. Bodzioch, M., E. Orso, J. Klucken, T. Langmann, A. Bottcher, W. Diederich, W. Drobnik, S. Barlage, C. Buchler, M. Porsch-Ozcurumez, et al. 1999. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat. Genet. 22: 347-351.
37. Rust, S., M. Rosier, H. Funke, J. Real, Z. Amoura, J. C. Piette, J. F. Deleuze, H. B. Brewer, N. Duverger, P. Denefle, et al. 1999. Tangier disease is caused by mutations in the gene encoding ATPbinding cassette transporter 1. Nat. Genet. 22: 352-355.
38. Garcia, C. K., K. Wilund, M. Arca, G. Zuliani, R. Fellin, M. Maioli, S. Calandra, S. Bertolini, F. Cossu, N. Grishin, et al. 2001. Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein. Science. 292: 1394-1398.
39. Peterfy, M., J. Phan, P. Xu, and K. Reue. 2001. Lipodystrophy in the fld mouse results from mutation of a new gene encoding a nuclear protein, lipin. Nat. Genet. 27: 121-124.
40. Reue, K., and J. Donkor. 2006. Lipin: a determinant of adiposity, insulin sensitivity and energy balance. Future Lipidol. 1: 91-101.
41. Phan, J., M. Peterfy, and K. Reue. 2004. Lipin expression preceding peroxisome proliferator-activated receptor-gamma is critical for adipogenesis in vivo and in vitro. J. Biol. Chem. 279: 29558-29564.
42. Peterfy, M., J. Phan, and K. Reue. 2005. Alternatively spliced lipin isoforms exhibit distinct expression pattern, subcellular localization, and role in adipogenesis. J. Biol. Chem. 280: 32883-32889.
43. Phan, J., and K. Reue. 2005. Lipin, a lipodystrophy and obesity gene. Cell Metab. 1: 73-83.
44. Suviolahti, E., K. Reue, R. M. Cantor, J. Phan, M. Gentile, J. Naukkarinen, A. Soro-Paavonen, L. Oksanen, J. Kaprio, A. Rissanen, et al. 2006. Cross-species analyses implicate Lipin 1 involvement in human glucose metabolism. Hum. Mol. Genet. 15: 377-386.
45. Santos-Rosa, H., J. Leung, N. Grimsey, S. Peak-Chew, and S. Siniossoglou. 2005. The yeast lipin Smp2 couples phospholipid biosynthesis to nuclear membrane growth. EMBO J. 24: 1931-1941.
46. 2+-dependent phosphatidate phosphatase enzyme. J. Biol. Chem. 281: 9210-9218.
47. Bodnar, J. S., A. Chatterjee, L. W. Castellani, D. A. Ross, J. Ohmen, J. Cavalcoli, C. Wu, K. M. Dains, J. Catanese, M. Chu, et al. 2002. Positional cloning of the combined hyperlipidemia gene Hyplip1. Nat. Genet. 30: 110-116.
48. Castellani, L. W., A. Weinreb, J. Bodnar, A. M. Goto, M. Doolittle, M. Mehrabian, P. Demant, and A. J. Lusis. 1998. Mapping a gene for combined hyperlipidaemia in a mutant mouse strain. Nat. Genet. 18: 374-377.
49. Hui, T. Y., S. S. Sheth, J. M. Diffley, D. W. Potter, A. J. Lusis, A. D. Attie, and R. A. Davis. 2004. Mice lacking thioredoxin-interacting protein provide evidence linking cellular redox state to appropriate response to nutritional signals. J. Biol. Chem. 279: 24387-24393.
50. -/- mice. J. Nutr. 134: 1475-1480.
51. Sheth, S. S., L. W. Castellani, S. Chari, C. Wagg, C. K. Thipphavong, J. S. Bodnar, P. Tontonoz, A. D. Attie, G. D. Lopaschuk, and A. J. Lusis. 2005. Thioredoxin-interacting protein deficiency disrupts the fasting-feeding metabolic transition. J. Lipid Res. 46: 123-134.
52. Minn, A. H., C. Hafele, and A. Shalev. 2005. Thioredoxin-interacting protein is stimulated by glucose through a carbohydrate response element and induces beta-cell apoptosis. Endocrinology. 146: 2397-2405.
53. Chen, K. S., and H. F. DeLuca. 1994. Isolation and characterization of a novel cDNA from HL-60 cells treated with 1,25-dihydroxyvitamin D-3. Biochim. Biophys. Acta. 1219: 26-32.
54. Ikarashi, M., Y. Takahashi, Y. Ishii, T. Nagata, S. Asai, and K. Ishikawa. 2002. Vitamin D3 up-regulated protein 1 (VDUP1) expression in gastrointestinal cancer and its relation to stage of disease. Anticancer Res. 22: 4045-4048.
55. Nishinaka, Y., A. Nishiyama, H. Masutani, S. Oka, K. M. Ahsan, Y. Nakayama, Y. Ishii, H. Nakamura, M. Maeda, and J. Yodoi. 2004. Loss of thioredoxin-binding protein-2/vitamin D3 up-regulated protein 1 in human T-cell leukemia virus type I-dependent T-cell transformation: implications for adult T-cell leukemia leukemogenesis. Cancer Res. 64: 1287-1292.
56. Tome, M. E., D. B. Johnson, L. M. Rimsza, R. A. Roberts, T. M. Grogan, T. P. Miller, L. W. Oberley, and M. M. Briehl. 2005. A redox signature score identifies diffuse large B-cell lymphoma patients with a poor prognosis. Blood. 106: 3594-3601.
57. Sheth, S. S., J. S. Bodnar, A. Ghazalpour, C. K. Thipphavong, S. Tsutsumi, A. D. Tward, P. Demant, T. Kodama, H. Aburatani, and A. J. Lusis. 2006. Hepatocellular carcinoma in Txnip-deficient mice. Oncogene. 25: 3528-3536.
58. Nakamura, M., and K. Yamada. 1967. Studies on a diabetic (KK) strain of the mouse. Diabetologia. 3: 212-221.
59. Koishi, R., Y. Ando, M. Ono, M. Shimamura, H. Yasumo, T. Fujiwara, H. Horikoshi, and H. Furukawa. 2002. Angptl3 regulates lipid metabolism in mice. Nat. Genet. 30: 151-157.
60. Camenisch, G., M. T. Pisabarro, D. Sherman, J. Kowalski, M. Nagel, P. Hass, M. H. Xie, A. Gurney, S. Bodary, X. H. Liang, et al. 2002. ANGPTL3 stimulates endothelial cell adhesion and migration via integrin alpha vbeta 3 and induces blood vessel formation in vivo. J. Biol. Chem. 277: 17281-17290.
61. Kaplan, R., T. Zhang, M. Hernandez, F. X. Gan, S. D. Wright, M. G. Waters, and T. Q. Cai. 2003. Regulation of the angiopoietin-like protein 3 gene by LXR. J. Lipid Res. 44: 136-143.
62. Shimamura, M., M. Matsuda, S. Kobayashi, Y. Ando, M. Ono, R. Koishi, H. Furukawa, M. Makishima, and I. Shimomura. 2003. Angiopoietin-like protein 3, a hepatic secretory factor, activates lipolysis in adipocytes. Biochem. Biophys. Res. Commun. 301: 604-609.
63. Ando, Y., T. Shimizugawa, S. Takeshita, M. Ono, M. Shimamura, R. Koishi, and H. Furukawa. 2003. A decreased expression of angiopoietin-like 3 is protective against atherosclerosis in apoE-deficient mice. J. Lipid Res. 44: 1216-1223.
64. Korstanje, R., P. Eriksson, A. Samnegard, P. G. Olsson, K. Forsman-Semb, S. Sen, G. A. Churchill, J. Rollins, S. Harris, A. Hamsten, et al. 2004. Locating Ath8, a locus for murine atherosclerosis susceptibility and testing several of its candidate genes in mice and humans. Atherosclerosis. 177: 443-450.
65. Oike, Y., M. Akao, Y. Kubota, and T. Suda. 2005. Angiopoietin-like proteins: potential new targets for metabolic syndrome therapy. Trends Mol. Med. 11: 473-479.
66. Li, C. 2006. Genetics and regulation of angiopoietin-like proteins 3 and 4. Curr. Opin. Lipidol. 17: 152-156.
67. Inaba, T., M. Matsuda, M. Shimamura, N. Takei, N. Terasaka, Y. Ando, H. Yasumo, R. Koishi, M. Makishima, and I. Shimomura. 2003. Angiopoietin-like protein 3 mediates hypertriglyceridemia induced by the liver X receptor. J. Biol. Chem. 278: 21344-21351.
68. Fugier, C., J. J. Tousaint, X. Prieur, M. Plateroti, J. Samarut, and P. Delerive. 2006. The lipoprotein lipase inhibitor ANGPTL3 is negatively regulated by thyroid hormone. J. Biol. Chem. 281: 11553-11559.
69. Paigen, B., A. Morrow, C. Brandon, D. Mitchell, and P. Holmes. 1985. Variation in susceptibility to atherosclerosis among inbred strains of mice. Atherosclerosis. 57: 65-73.
70. Mouzeyan, A., J. Choi, H. Allayee, X. Wang, J. Sinsheimer, J. Phan, L. W. Castellani, K. Reue, A. J. Lusis, and R. C. Davis. 2000. A locus conferring resistance to diet-induced hypercholesterolemia and atherosclerosis on mouse chromosome 2. J. Lipid Res. 41: 573-582.
71. Phan, J., T. Pesaran, R. C. Davis, and K. Reue. 2002. The Diet1 locus confers protection against hypercholesterolemia through enhanced bile acid metabolism. J. Biol. Chem. 277: 469-477.
72. Vergnes, L., J. Phan, M. Strauss, S. Tafuri, and K. Reue. 2003. Cholesterol and cholate components of an atherogenic diet induce distinct stages of hepatic inflammatory gene expression. J. Biol. Chem. 278: 42774-42784.
73. Silver, L. M. 1995. Mouse Genetics. Concepts and Applications. Oxford University Press, New York.
74. Mehrabian, M., H. Allayee, J. Wong, W. Shi, X. P. Wang, Z. Shaposhnik, C. D. Funk, and A. J. Lusis. 2002. Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice. Circ. Res. 91: 120-126.
75. Wang, X., M. Ria, P. M. Kelmenson, P. Eriksson, D. C. Higgins, A. Samnegard, C. Petros, J. Rollins, A. M. Bennet, B. Wiman, et al. 2005. Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility. Nat. Genet. 37: 365-372.
76. Clee, S. M., B. S. Yandell, K. M. Schueler, M. E. Rabaglia, O. C. Richards, S. M. Raines, E. A. Kabara, D. M. Klass, E. T. Mui, D. S. Stapleton, et al. 2006. Positional cloning of Sorcs1, a type 2 diabetes quantitative trait locus. Nat. Genet. 38: 688-693.
77. Hansson, D. K., P. Libby, U. Schonbeck, and Z. Q. Yean. 2002. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ. Res. 91: 281-291.
78. Mehrabian, M., and H. Allayee. 2003. 5-Lipoxygenase and atherosclerosis. Curr. Opin. Lipidol. 14: 447-457.
79. Ghazalpour, A., S. Doss, X. Yang, J. Aten, E. M. Toomey, A. Van Nas, S. Wang, T. A. Drake, and A. J. Lusis. 2004. Thematic review series: The pathogenesis of atherosclerosis. Toward a biological network for atherosclerosis. J. Lipid Res. 45: 1793-1805.
80. Drake, T. A., E. E. Schadt, and A. J. Lusis. 2006. Integrating genetic and gene expression data: application to cardiovascular and metabolic traits in mice. Mamm. Genome. 17: 466-479.
81. Petretto, E., J. Mangion, M. Pravanec, N. Hubner, and T. J. Aitman. 2006. Integrated gene expression profiling and linkage analysis in the rat. Mamm. Genome. 17: 480-489.
82. Williams, R. W. 2006. Expression genetics and the phenotype revolution. Mamm. Genome. 17: 496-502.
83. Cervino, A. C., G. Li, S. Edwards, J. Zhu, C. Laurie, G. Tokiwa, P. Y. Lum, S. Wang, L. W. Castellini, A. J. Lusis, et al. 2005. Integrating QTL and high-density SNP analyses in mice to identify Insig2 as a susceptibility gene for plasma cholesterol levels. Genomics. 86: 505-517.
84. Mehrabian, M., H. Allayee, J. Stockton, P. Y. Lum, T. A. Drake, L. W. Castellani, M. Suh, C. Armour, S. Edwards, J. Lamb, et al. 2005. Integrating genotypic and expression data in a segregating mouse population to identify 5-lipoxygenase as a susceptibility gene for obesity and bone traits. Nat. Genet. 37: 1224-1233.
85. Schadt, E. E., S. A. Monks, T. A. Drake, A. J. Lusis, N. Che, V. Colinayo, T. G. Ruff, S. B. Milligan, J. R. Lamb, G. Cavet, et al. 2003. Genetics of gene expression surveyed in maize, mouse and man. Nature. 422: 297-302.
86. Wang, S., N. Yehya, E. E. Schadt, H. Wang, T. A. Drake, and A. J. Lusis. 2006. Genetic and genomic analysis of a fat mass trait with complex inheritance reveals marked sex specificity. PLoS Genet. 2: 148-159.
87. Lan, H., M. Chen, J. B. Flowers, B. S. Yandell, D. S. Stapleton, C. M. Mata, E. T. Mui, M. T. Flowers, K. L. Schueler, K. F. Manly, et al. 2006. Combined expression trait correlations and expression quantitative trait locus mapping. PLoS Genet. 2: 51-61.
88. Lum, P. Y., Y. Chen, J. Zhu, J. Lamb, S. Melmed, S. Wang, T. A. Drake, A. J. Lusis, and E. E. Schadt. 2006. Elucidating the murine brain transcriptional network in a segregating mouse population to identify core functional modules for obesity and diabetes. J. Neurochem. 97(Suppl. 1): 50-62.
89. Castro Cabezas, M. 2003. Postprandial lipaemia in familial combined hyperlipidaemia. Biochem. Soc. Trans. 31: 1090-1093.
90. Pajukanta, P., J. S. Bodnar, R. Sallinen, M. Chu, T. Airaksinen, Q. Xiao, L. W. Castellani, S. S. Sheth, M. Wessman, A. Palotie, et al. 2001. Fine mapping of Hyplip1 and the human homolog, a potential locus for FCHL. Mamm. Genome. 12: 238-245.
91. Pajukanta, P., H. E. Lilja, J. S. Sinsheimer, R. M. Cantor, A. J. Lusis, M. Gentile, X. J. Duan, A. Soro-Paavonen, J. Naukkarinen, J. Saarela, et al. 2004. Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1). Nat. Genet. 36: 371-376.
92. Huertas-Vazquez, A., C. Aguilar-Salinas, A. J. Lusis, R. M. Cantor, S. Canizales-Quinteros, J. C. Lee, L. Mariana-Nunez, R. M. Riba-Ramirez, A. Jokiaho, T. Tusie-Luna, et al. 2005. Familial combined hyperlipidemia in Mexicans: association with upstream transcription factor 1 and linkage on chromosome 16q24.1. Arterioscler. Thromb. Vasc. Biol. 25: 1985-1991.
93. Putt, W., J. Palmen, V. Nicaud, D. A. Tregouet, N. Tahri-Daizadeh, D. M. Flavell, S. E. Humphries, and P. J. Talmud. 2004. Variation in USF1 shows haplotype effects, gene:gene and gene:environment associations with glucose and lipid parameters in the European Atherosclerosis Research Study II. Hum. Mol. Genet. 13: 1587-1597.
94. Suviolahti, E., L. J. Oksanen, M. Ohman, R. M. Cantor, M. Ridderstrale, T. Tuomi, J. Kaprio, A. Rissanen, P. Mustajoki, P. Jousilahti, et al. 2003. The SLC6A14 gene shows evidence of association with obesity. J. Clin. Invest. 112: 1762-1772.
95. Wang, Q. 2005. Molecular genetics of coronary artery disease. Curr. Opin. Cardiol. 20: 182-188.
96. van der Weyden, L., D. J. Adams, and A. Bradley. 2002. Tools for targeted manipulation of the mouse genome. Physiol. Genomics. 11: 133-164.
97. Glaser, S., K. Anastassiadis, and A. F. Stewart. 2005. Current issues in mouse genome engineering. Nat. Genet. 37: 1187-1193.
98. Austin, C. P., J. F. Battey, A. Bradley, M. Bucan, M. Capecchi, F. S. Collins, W. F. Dove, G. Duyk, S. Dymecki, J. T. Eppig, et al. 2004. The knockout mouse project. Nat. Genet. 36: 921-924.
99. Auwerx, J., P. Avner, R. Baldock, A. Ballabio, R. Balling, M. Barbacid, A. Berns, A. Bradley, S. Brown, P. Carmeliet, et al. 2004. The European dimension for the mouse genome mutagenesis program. Nat. Genet. 36: 925-927.
100. Winzeler, E. A., D. D. Shoemaker, A. Astromoff, H. Liang, K. Anderson, B. Andre, R. Bangham, R. Benito, J. D. Boeke, H. Bussey, et al. 1999. Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science. 285: 901-906.
101. Sugimoto, A. 2004. High-throughput RNAiin Caenorhabditis elegans: genome-wide screens and functional genomics. Differentiation. 72: 81-91.
102. Ashrafi, K., F. Y. Chang, J. L. Watts, A. G. Fraser, R. S. Kamath, J. Ahringer, and G. Ruvkun. 2003. Genome-wide RNAi analysis of Caenorhabditis elegans fat regulatory genes. Nature. 421: 268-272.
103. Cullen, L. M., and G. M. Arndt. 2005. Genome-wide screening for gene function using RNAi in mammalian cells. Immunol. Cell Biol. 83: 217-223.
104. Yu, J., and A. P. McMahon. 2006. Reproducible and inducible knockdown of gene expression in mice. Genesis. 44: 252-261.
105. Williams, R. W., L. Flaherty, and D. W. Threadgill. 2003. The math of making mutant mice. Genes Brain Behav. 2: 191-200.
106. Guenet, J. L. 2004. Chemical mutagenesis of the mouse genome: an overview. Genetica. 122: 9-24.
107. Clark, A. T., D. Goldowitz, J. S. Takahashi, M. H. Vitaterna, S. M. Siepka, L. L. Peters, W. N. Frankel, G. A. Carlson, J. Rossant, J. H. Nadeau, et al. 2004. Implementing large-scale ENU mutagenesis screens in North America. Genetica. 122: 51-64.
108. Cordes, S. P. 2005. N-Ethyl-N-nitrosourea mutagenesis: boarding the mouse mutant express. Microbiol. Mol. Biol. Rev. 69: 426-439.
109. Justice, M. J., J. K. Noveroske, J. S. Weber, B. Zheng, and A. Bradley. 1999. Mouse ENU mutagenesis. Hum. Mol. Genet. 8: 1955-1963.
110. Nolan, P. M., J. Peters, M. Strivens, D. Rogers, J. Hagan, N. Spurr, I. C. Gray, L. Vizor, D. Brooker, E. Whitehill, et al. 2000. A systematic, genome-wide, phenotype-driven mutagenesis programme for gene function studies in the mouse. Nat. Genet. 25: 440-443.
111. Hrabe de Angelis, M. H., H. Flaswinkel, H. Fuchs, B. Rathkolb, D. Soewarto, S. Marschall, S. Heffner, W. Pargent, K. Wuensch, M. Jung, et al. 2000. Genome-wide, large-scale production of mutant mice by ENU mutagenesis. Nat. Genet. 25: 444-447.
112. Hough, T. A., P. M. Nolan, V. Tsipouri, A. A. Toye, I. C. Gray, M. Goldsworthy, L. Moir, R. D. Cox, S. Clements, P. H. Glenister, et al. 2002. Novel phenotypes identified by plasma biochemical screening in the mouse. Mamm. Genome. 13: 595-602.
113. Mohr, M., M. Klempt, B. Rathkolb, M. H. de Angelis, E. Wolf, and B. Aigner. 2004. Hypercholesterolemia in ENU-induced mouse mutants. J. Lipid Res. 45: 2132-2137.
114. Hoebe, K., P. Georgel, S. Rutschmann, X. Du, S. Mudd, K. Crozat, S. Sovath, L. Shamel, T. Hartung, U. Zahringer, et al. 2005. CD36 is a sensor of diacylglycerides. Nature. 433: 523-527.
115. Quwailid, M. M., A. Hugill, N. Dear, L. Vizor, S. Wells, E. Horner, S. Fuller, J. Weedon, H. McMath, P. Woodman, et al. 2004. A gene-driven ENU-based approach to generating an allelic series in any gene. Mamm. Genome. 15: 585-591.
116. Michaud, E. J., C. T. Culiat, M. L. Klebig, P. E. Barker, K. T. Cain, D. J. Carpenter, L. L. Easter, C. M. Foster, A. W. Gardner, Z. Y. Guo, et al. 2005. Efficient gene-driven germ-line point mutagenesis of C57BL/6J mice. BMC Genomics. 6: 1-18.
117. Augustin, M., R. Sedlmeier, T. Peters, U. Huffstadt, E. Kochmann, D. Simon, M. Schoniger, S. Garke-Mayerthaler, J. Laufs, M. Mayhaus, et al. 2005. Efficient and fast targeted production of murine models based on ENU mutagenesis. Mamm. Genome. 16: 405-413.
118. Stanford, W. L., J. B. Cohn, and S. P. Cordes. 2001. Gene-trap mutagenesis: past, present and beyond. Nat. Rev. Genet. 2: 756-768.
119. Skarnes, W. C., H. von Melchner, W. Wurst, G. Hicks, A. S. Nord, T. Cox, S. G. Young, P. Ruiz, P. Soriano, M. Tessier-Lavigne, et al. 2004. A public gene trap resource for mouse functional genomics. Nat. Genet. 36: 543-544.
120. Nord, A. S., P. J. Chang, B. R. Conklin, A. V. Cox, C. A. Harper, G. G. Hicks, C. C. Huang, S. J. Johns, M. Kawamoto, S. Liu, et al. 2006. The International Gene Trap Consortium Website: a portal to all publicly available gene trap cell lines in mouse. Nucleic Acids Res. 34: D642-D648.
121. Beigneux, A. P., C. Kosinski, B. Gavino, J. D. Horton, W. C. Skarnes, and S. G. Young. 2004. ATP-citrate lyase deficiency in the mouse. J. Biol. Chem. 279: 9557-9564.
122. Steenbergen, R., T. S. Nanowski, A. Beigneux, A. Kulinski, S. G. Young, and J. E. Vance. 2005. Disruption of the phosphatidylserine decarboxylase gene in mice causes embryonic lethality and mitochondrial defects. J. Biol. Chem. 280: 40032-40040.
123. Bergo, M. O., B. J. Gavino, R. Steenbergen, B. Sturbois, A. F. Parlow, D. A. Sanan, W. C. Skarnes, J. E. Vance, and S. G. Young. 2002. Defining the importance of phosphatidylserine synthase 2 in mice. J. Biol. Chem. 277: 47701-47708.
124. Steenbergen, R., T. S. Nanowski, R. Nelson, S. G. Young, and J. E. Vance. 2006. Phospholipid homeostasis in phosphatidylserine synthase-2-deficient mice. Biochim. Biophys. Acta. 1761: 313-323.
125. Agarwal, A. K., E. Arioglu, S. De Almeida, N. Akkoc, S. I. Taylor, A. M. Bowcock, R. I. Barnes, and A. Garg. 2002. AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34. Nat. Genet. 31: 21-23.
126. Gale, S. E., A. Frolov, X. Han, P. E. Bickel, L. Cao, A. Bowcock, J. E. Schaffer, and D. S. Ory. 2006. A regulatory role for 1-acylglycerol-3-phosphate- O-acyltransferase 2 in adipocyte differentiation. J. Biol. Chem. 281: 11082-11089.
127. Beigneux, A. P., L. Vergnes, X. Qiao, S. Quatela, R. Davis, S. M. Watkins, R. A. Coleman, R. L. Walzem, M. Philips, K. Reue, et al. 2006. Agpat6 - a novel lipid biosynthetic gene required for triacylglycerol production in mammary epithelium. J. Lipid Res. 47: 734-744.
128. Vergnes, L., A. P. Beigneux, R. Davis, S. M. Watkins, S. G. Young, and K. Reue. 2006. Agpat6 deficiency causes subdermal lipodystrophy and resistance to obesity. J. Lipid Res. 47: 745-754.
129. Friedel, R. H., A. Plump, X. Lu, K. Spilker, C. Jolicoeur, K. Wong, T. R. Venkatesh, A. Yaron, M. Hynes, B. Chen, et al. 2005. Gene targeting using a promoterless gene trap vector ("targeted trapping") is an efficient method to mutate a large fraction of genes. Proc. Natl. Acad. Sci. USA. 102: 13188-13193.
130. Warming, S., N. Costantino, D. L. Court, N. A. Jenkins, and N. G. Copeland. 2005. Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Res. 33: 1-12.
131. Testa, G., Y. Zhang, K. Vintersten, V. Benes, W. W. Pijnappel, I. Chambers, A. J. Smith, A. G. Smith, and A. F. Stewart. 2003. Engineering the mouse genome with bacterial artificial chromosomes to create multipurpose alleles. Nat. Biotechnol. 21: 443-447.
132. Meiner, V. L., C. L. Welch, S. Cases, H. M. Myers, E. Sande, A. J. Lusis, and R. V. Farese, Jr. 1998. Adrenocortical lipid depletion gene (ald) in AKR mice is associated with an acyl-CoA:cholesterol acyltransferase (ACAT) mutation. J. Biol. Chem. 273: 1064-1069.
133. Hou, X., M. Mrug, B. K. Yoder, E. J. Lefkowitz, G. Kremmidiotis, P. D'Eustachio, D. R. Beier, and L. M. Guay-Woodford. 2002. Cystin, a novel cilia-associated protein, is disrupted in the cpk mouse model of polycystic kidney disease. J. Clin. Invest. 109: 533-540.
134. Lu, K., H. Nishimori, Y. Nakamura, K. Shima, and M. Kuwajima. 1998. A missense mutation of mouse OCTN2, a sodium-dependent carnitine cotransporter, in the juvenile visceral steatosis mouse. Biochem. Biophys. Res. Commun. 252: 590-594.
135. Nezu, J., I. Tamai, A. Oku, R. Ohashi, H. Yabuuchi, N. Hashimoto, H. Nikaido, Y. Sai, A. Koizumi, Y. Shoji, et al. 1999. Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter. Nat. Genet. 21: 91-94.
136. Loftus, S. K., J. A. Morris, E. D. Carstea, J. Z. Gu, C. Cummings, A. Brown, J. Ellison, K. Ohno, M. A. Rosenfeld, D. A. Tagle, et al. 1997. Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene. Science. 277: 232-235.
137. Omran, H., K. Haffner, S. Burth, C. Fernandez, B. Fargier, A. Villaquiran, H. G. Nothwang, S. Schnittger, H. Lehrach, D. Woo, et al. 2001. Human adolescent nephronophthisis: gene locus synteny with polycystic kidney disease in pcy mice. J. Am. Soc. Nephrol. 12: 107-113.
138. Moulson, C. L., D. R. Martin, J. J. Lugus, J. E. Schaffer, A. C. Lind, and J. H. Miner. 2003. Cloning of wrinkle-free, a previously uncharacterized mouse mutation, reveals crucial roles for fatty acid transport protein 4 in skin and hair development. Proc. Natl. Acad. Sci. USA. 100: 5274-5279.